Orthopedic Companies Spot Opportunity in Ambulatory Settings

Forward-thinking orthopedic and spine companies seek to predict and capitalize on the movement of procedures to ambulatory facilities.

Stryker’s Return to Orthopedics’ Top Spot Years in the Making

Stryker and DePuy Synthes have grappled for the top spot in orthopedic sales for decades. We project that Stryker will reclaim the lead in 2021.

Member-Only Content

SUBSCRIBE Login

10 Orthopedic Companies to Watch for the Foreseeable Future

Numerous medium- and small-sized orthopedic companies are making bold strategic moves.

18 Orthopedic Companies Gain Funding

We recap 18 funding announcements that took place since June 2021. Many of the companies are familiar names with previously-closed funding rounds.

IPO Landscape Favorable for Orthopedic Players

Three companies – Treace Medical Concepts, Bioventus and Paragon 28 – made the leap in 2021. Market conditions could induce more to go public in 2022.

Member-Only Content

SUBSCRIBE Login

China’s Volume-Based Procurement Policy a Seismic Shift for Orthopedic Players

China's volume-based procurement policy recently came to hip and knee replacements, resulting in price declines of more than 80%.

Member-Only Content

SUBSCRIBE Login

Editor's Picks

Orthopedic Companies Spot Opportunity in Ambulatory Settings

Orthopedic Companies Spot Opportunity in Ambulatory Settings

Stryker’s Return to Orthopedics’ Top Spot Years in the Making

Stryker’s Return to Orthopedics’ Top Spot Years in the Making

Member-Only Content

10 Orthopedic Companies to Watch for the Foreseeable Future

10 Orthopedic Companies to Watch for the Foreseeable Future

18 Orthopedic Companies Gain Funding

18 Orthopedic Companies Gain Funding

IPO Landscape Favorable for Orthopedic Players

IPO Landscape Favorable for Orthopedic Players

Member-Only Content

China’s Volume-Based Procurement Policy a Seismic Shift for Orthopedic Players

China’s Volume-Based Procurement Policy a Seismic Shift for Orthopedic Players

Member-Only Content

Zimmer Biomet Enters New Level of Digital Technology with Launch ...

Zimmer Biomet Enters New Level of Digital Technology with Launch of Persona IQ

Zimmer Biomet’s Spin-Off Debuts as ZimVie

Zimmer Biomet’s Spin-Off Debuts as ZimVie

Corin Appoints Jacob Paul as CEO

Corin Appoints Jacob Paul as CEO

Johnson & Johnson CEO Alex Gorsky to Transition to Executive ...

Johnson & Johnson CEO Alex Gorsky to Transition to Executive Chairman in 2022